Učitavanje...
STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
The possibility of atorvastatin in reducing the risk of periprocedural myocardial infarction and other cardiovascular events in patients with percutaneous coronary intervention is discussed.
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Stolichnaya Izdatelskaya Kompaniya
2015-09-01
|
| Serija: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
| Teme: | |
| Online pristup: | https://www.rpcardio.com/jour/article/view/192 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|